The latest issue of Contact Lens Update – issue 69 – has been released, presenting free, evidence-based guidance from three experts to help eye

Scientists in the United States have used patient stem cells and 3D bioprinting to produce eye tissue that will help them study a range

Rare disease drug company Horizon Therapeutics, maker of eye disease drugs Tepezza and Uplizna, will be acquired by Amgen in a deal valued at

Pharmaceutical giant Merck & Co. has dropped a candidate for the treatment of geographic atrophy (GA), narrowing the scope of its long-standing collaboration with